Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Observational × Ovarian Epithelial Cancer Recurrent × Clear all

Status

Sponsor Class

Study Type

Interventional 2 Observational 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 1245 Neoplasms 1047 Colorectal Neoplasms 554 Lung Neoplasms 487 Prostatic Neoplasms 485 Carcinoma, Non-Small-Cell Lung 395 Carcinoma, Hepatocellular 252 Stomach Neoplasms 241 Pancreatic Neoplasms 237 Colonic Neoplasms 233 Ovarian Neoplasms 205 Head and Neck Neoplasms 202 Rectal Neoplasms 194 Melanoma 194 Multiple Myeloma 183 Uterine Cervical Neoplasms 172 Leukemia 168 Precursor Cell Lymphoblastic Leukemia-Lymphoma 167 Lymphoma 165 Esophageal Neoplasms 157 Neoplasm Metastasis 156 Carcinoma, Renal Cell 154 Brain Neoplasms 147 Leukemia, Myeloid, Acute 134 Urinary Bladder Neoplasms 120 Polycystic Ovary Syndrome 111 Recurrence 104 Hematologic Neoplasms 101 Liver Neoplasms 97 Endometrial Neoplasms 94

Interventions

liposomal doxorubicin 1 Trabectedin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02394015 2020-03-27

RETRO-ROC

Grupo Español de Investigación en Cáncer de Ovario

Ovarian Epithelial Cancer Recurrent

Data powered by HemOnc (CC BY 4.0) Colophon ⚡